| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210735 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 15 Pages |
Abstract
Concurrent treatment with SRS and PD-1 pathway inhibitors was associated with favorable OS and locoregional disease control. This combination of therapy was well tolerated and merits further evaluation in larger cohorts in a prospective setting.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Emily BA, Harper BS, Beow Y. PhD, William A. MD, MBA, Alice T. MD, PhD, Kevin MD, Justin F. MD, Helen A. MD,